IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $225,802 | +5.9% | 4,978 | -4.2% | 0.00% | 0.0% |
| Q2 2023 | $213,274 | -74.8% | 5,198 | -76.8% | 0.00% | -75.0% |
| Q4 2022 | $846,539 | -99.9% | 22,413 | -51.1% | 0.01% | -27.3% |
| Q3 2022 | $1,015,014,000 | +120020.0% | 45,850 | +100.8% | 0.01% | +22.2% |
| Q2 2022 | $845,000 | -3.4% | 22,831 | -3.3% | 0.01% | 0.0% |
| Q1 2022 | $875,000 | +46.1% | 23,617 | +20.0% | 0.01% | +50.0% |
| Q4 2021 | $599,000 | -36.1% | 19,681 | -29.5% | 0.01% | -33.3% |
| Q3 2021 | $937,000 | +2.9% | 27,924 | +22.2% | 0.01% | -10.0% |
| Q2 2021 | $911,000 | -11.7% | 22,846 | -0.5% | 0.01% | -23.1% |
| Q1 2021 | $1,032,000 | – | 22,950 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |